Molecular Diagnostics Reports Bundle - WTRF 7 News Sports Weather - Wheeling Steubenville

Molecular Diagnostics Reports Bundle

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact

SOURCE Research and Markets

DUBLIN, Ireland, April 17, 2014 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Molecular Diagnostics Reports Bundle" report to their offering. 
     (Logo: )

The Molecular Diagnostics Reports Bundle includes the following publications at a 15% discount off the individual reports being purchased separately:

  • Molecular Diagnostics in Cancer Testing
  • Molecular Diagnostics in Genetic Testing
  • Molecular Diagnostics in Infectious Disease Testing
  • Molecular Diagnostics Markets

Below are summaries of each report as well as links to purchase the individual titles. 

'Molecular Diagnostics in Cancer Testing'

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for cancer, the screening, diagnosis and classification of cancer patients, and the optimization of drug therapy. 

This report describes the specific segment of the in vitro diagnostics (IVD) market known as molecular diagnostics (MD), with a specialization in the MD tests for cancer. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. The confluence of breakthroughs in genomics, proteomics, and the development of microarray devices to measure analytes in the blood and various body tissues, has led to this revolutionary market segment offering the power of advanced analytical techniques to the diagnosis and treatment of cancer. This report analyzes the size and growth of the molecular diagnostics market in its applications for cancer detection and therapy, examining the factors that influence the various market segments and the dollar volume of sales, both in the United States and worldwide.

Key Topics Covered: 

1. Overview

2. Introduction to Molecular Diagnostics

3. Cancer Diagnostics Molecular Testing Market

4. Molecular Diagnostic Tests for Cancer

5. Business

6. Reimbursement and Billing

7. Government Regulation

8. Business Decisions Using Molecular Diagnostic Tests in Drug Development

9. Company Profiles

Companies Mentioned:

  • ARCA biopharma
  • Abbott Laboratories
  • Adnavance Technologies, Inc.
  • AdvanDx
  • Agendia
  • Agilent Technologies
  • Ambry Genetics
  • American Diagnostica
  • Applied Biosystems, Inc. (now Life Technologies)
  • ArcticDx, Inc.
  • Arcxis Biotechnologies
  • Asuragen
  • Atlas Genetics
  • Aureon Laboratories
  • AutoGenomics, Inc
  • BG Medicine
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • BioGenex Laboratories, Inc
  • BioHelix Corporation
  • Biocartis
  • Biotage AB
  • Biotest AG
  • Caliper Life Sciences, Inc.
  • Celera
  • Cepheid
  • Clarient, Inc.
  • CombiMatrix Corporation
  • CytoCore, Inc.
  • Cytocell Technologies Ltd.
  • DiagnoCure, Inc.
  • DxS
  • EXACT Sciences Corporation
  • EntroGen, Inc
  • Enzo Biochem
  • Epigenomics
  • EraGen Biosciences
  • Eurogentec
  • Exact Sciences Corporation
  • Exagen Diagnostics, Inc.
  • Exiqon A/S
  • Ferrer inCode
  • Gen-Probe
  • GenMark Diagnostics, Inc.
  • Gene Express
  • GeneOhm Sciences
  • Genera Biosystems
  • Genmark Diagnostics, Inc
  • Genomic Health, Inc.
  • Genomica
  • Genomix Biotech
  • Genoptix, Inc.
  • Genzyme Corporation
  • Great Basin Scientific
  • Hologic, Inc
  • Illumina, Inc
  • Innogenetics NV
  • IntegenX
  • InterGenetics, Inc.
  • Inverness Medical Innovations
  • Invitrogen (Life Technologies)
  • LabCorp
  • Laboratory Corporation of America Holdings
  • Life Technologies Corporation
  • Luminex
  • Luminex Corporation
  • Mobidiag
  • Monogram Biosciences, Inc.
  • Myconostica
  • Myriad Genetics, Inc
  • Nanogen
  • Nanosphere
  • Natera
  • NetBio
  • NorDiag ASA
  • Nuvera Biosciences
  • Orion Genomics
  • PANTHER System
  • PerkinElmer Genetics
  • PharMingen
  • Progenika, Inc
  • Roche Ltd
  • Rosetta Genomics Ltd.
  • SABiosciences Corporation
  • SIRS-Lab
  • Seegene
  • Sequenom, Inc.
  • Siemens Healthcare Diagnostics (Siemens)
  • Signature Genomics
  • Source MDx
  • Spartan Bioscience, Inc
  • Targeted Molecular Diagnostics
  • Thermo Fisher Scientific
  • Thorne Diagnostics
  • Transgenomic, Inc
  • TrimGen
  • TrovaGene
  • U.S. Genomics, Inc.
  • Veredus Laboratories
  • Veridex
  • Xenomics, Inc.
  • bioMerieux
  • bioTheranostics

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716,

©2012 PR Newswire. All Rights Reserved.